Icosavax Funding & Investors
Seattle, WA
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.
icosavax.comTotal Amount Raised: $235,300,000
Icosavax Funding Rounds
Post Ipo Equity
$67,800,000
Post Ipo Equity Investors
TCG Crossover ManagementLogos CapitalVivo CapitalSeries B
$100,000,000
Series B Investors
RA Capital ManagementAdams Street PartnersJanus Henderson GroupSurveyor Capital+ND CapitalCormorant Asset ManagementPerceptive AdvisorsOpen PhilanthropyOmega Fund ManagementViking Global InvestorsQiming Venture Partners USAGenzymeIPO
Unknown
Grant
$10,000,000
Grant Investors
Bill & Melinda Gates FoundationGrant
$6,500,000
Grant Investors
Good VenturesSeries A
$51,000,000
Series A Investors
Qiming Venture Partners USAAdams Street Partnerssanofi-aventis+ND CapitalGenzyme
Funding info provided by Diffbot.